Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
17
pubmed:dateCreated
2004-9-9
pubmed:abstractText
The purpose of this work was to provide a scientific basis for specific immunotherapy of colon cancer.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1078-0432
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5828-36
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15355913-Adenocarcinoma, pubmed-meshheading:15355913-Animals, pubmed-meshheading:15355913-Antigens, Neoplasm, pubmed-meshheading:15355913-COS Cells, pubmed-meshheading:15355913-Carcinoma, Squamous Cell, pubmed-meshheading:15355913-Cell Proliferation, pubmed-meshheading:15355913-Cercopithecus aethiops, pubmed-meshheading:15355913-Colonic Neoplasms, pubmed-meshheading:15355913-Epitopes, T-Lymphocyte, pubmed-meshheading:15355913-Esophageal Neoplasms, pubmed-meshheading:15355913-HLA-A2 Antigen, pubmed-meshheading:15355913-Humans, pubmed-meshheading:15355913-Lymphocytes, Tumor-Infiltrating, pubmed-meshheading:15355913-Nucleotide Deaminases, pubmed-meshheading:15355913-Peptide Fragments, pubmed-meshheading:15355913-Phosphoglycerate Kinase, pubmed-meshheading:15355913-RNA, Messenger, pubmed-meshheading:15355913-T-Lymphocytes, Cytotoxic, pubmed-meshheading:15355913-Thymidylate Synthase, pubmed-meshheading:15355913-Tumor Cells, Cultured
pubmed:year
2004
pubmed:articleTitle
Two proliferation-related proteins, TYMS and PGK1, could be new cytotoxic T lymphocyte-directed tumor-associated antigens of HLA-A2+ colon cancer.
pubmed:affiliation
Department of Immunology, Kurume University School of Medicine, Research Center of Innovative Cancer Therapy of the 21st Century COE Program for Medical Science, Kurume University, Kurume, Fukuoka, Japan. shichijo@med.kurume-u.ac.jp
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't